» Articles » PMID: 39309185

Antibiotic-Polyphosphate Nanocomplexes: A Promising System for Effective Biofilm Eradication

Overview
Publisher Dove Medical Press
Specialty Biotechnology
Date 2024 Sep 23
PMID 39309185
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: The eradication of bacterial biofilms poses an enormous challenge owing to the inherently low antibiotic susceptibility of the resident microbiota. The complexation of antibiotics with polyphosphate can substantially improve antimicrobial performance.

Methods: Nanoparticular complexes of the model drug colistin and polyphosphate (CP-NPs) were developed and characterized in terms of their particle size and morphology, polydispersity index (PDI), zeta potential, and cytotoxicity. Enzyme-triggered monophosphate and colistin release from the CP-NPs was evaluated in the presence of alkaline phosphatase (AP). Subsequently, antimicrobial efficacy was assessed by inhibition experiments on planktonic cultures, as well as time-kill assays on biofilms formed by the model organism .

Results: The CP-NPs exhibited a spherical morphology with particle sizes <200 nm, PDI <0.25, and negative zeta potential. They showed reduced cytotoxicity toward two human cell lines and significantly decreased hemotoxicity compared with native colistin. Release experiments with AP verified the enzymatic cleavage of polyphosphate and subsequent release of monophosphate and colistin from CP-NPs. Although CP-NPs were ineffective against planktonic cultures, they showed major activity against bacterial biofilms, outperforming native colistin treatment. Strongly elevated AP levels in the biofilm state were identified as a potential key factor for the observed findings.

Conclusion: Accordingly, polyphosphate-based nanocomplexes represent a promising tool to tackle bacterial biofilm.

References
1.
Akkus-Dagdeviren Z, Furst A, Friedl J, Tribus M, Bernkop-Schnurch A . Nanoarchitectonics of Layer-by-Layer (LbL) coated nanostructured lipid carriers (NLCs) for Enzyme-Triggered charge reversal. J Colloid Interface Sci. 2022; 629(Pt A):541-553. DOI: 10.1016/j.jcis.2022.08.190. View

2.
Ianniello N, Andrade D, Ivancic S, Eckardt P, Lemos Ramirez J . Native valve infective endocarditis due to in a non-Hodgkin's lymphoma patient. IDCases. 2019; 18:e00657. PMC: 6921130. DOI: 10.1016/j.idcr.2019.e00657. View

3.
Ahmed M, Zhong L, Shen C, Yang Y, Doi Y, Tian G . Colistin and its role in the Era of antibiotic resistance: an extended review (2000-2019). Emerg Microbes Infect. 2020; 9(1):868-885. PMC: 7241451. DOI: 10.1080/22221751.2020.1754133. View

4.
Liu Y, Kuo S, Yao B, Fang Z, Lee Y, Chang Y . Colistin nanoparticle assembly by coacervate complexation with polyanionic peptides for treating drug-resistant gram-negative bacteria. Acta Biomater. 2018; 82:133-142. DOI: 10.1016/j.actbio.2018.10.013. View

5.
Saleh A, Akkus-Dagdeviren Z, Friedl J, Knoll P, Bernkop-Schnurch A . Chitosan - Polyphosphate nanoparticles for a targeted drug release at the absorption membrane. Heliyon. 2022; 8(9):e10577. PMC: 9513768. DOI: 10.1016/j.heliyon.2022.e10577. View